Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-033335

Director sold 86,270 shares at an average $11.16 ($962,907)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Canaan IX L.P. Director 2016-11-10 Sale −27,135 $11.07 $300,390 3,903,516 I: show line 1 in the form
Canaan IX L.P. Director 2016-11-11 Sale −35,391 $11.20 $396,461 3,868,125 I: show line 2 in the form
Canaan IX L.P. Director 2016-11-14 Sale −23,744 $11.21 $266,056 3,844,381 I: show line 3 in the form
Open-market sales · 86,270 sh · avg $11.16 · $962,907
Loading xslF345X03/doc4.xml…